Research output per year
Research output per year
Fingerprint
Dive into the research topics where Catherine S Perry is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research output
-
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity
Ripperger, T. J., Uhrlaub, J. L., Watanabe, M., Wong, R., Castaneda, Y., Pizzato, H. A., Thompson, M. R., Bradshaw, C., Weinkauf, C. C., Bime, C., Erickson, H. L., Knox, K., Bixby, B., Parthasarathy, S., Chaudhary, S., Natt, B., Cristan, E., El Aini, T., Rischard, F., Campion, J. & 17 others, , Nov 17 2020, In: Immunity. 53, 5, p. 925-933.e4Research output: Contribution to journal › Article › peer-review
Open Access59 Scopus citations -
Continued excellent outcomes in previously untreated patients with follicular lymphoma after treatment with CHOP plus rituximab or CHOP plus 131I-Tositumomab: Long-Term follow-up of phase III randomized study SWOG-S0016
Shadman, M., Li, H., Rimsza, L., Leonard, J. P., Kaminski, M. S., Braziel, R. M., Spier, C. M., Gopal, A. K., Maloney, D. G., Cheson, B. D., Dakhil, S., LeBlanc, M., Smith, S. M., Fisher, R. I., Friedberg, J. W. & Press, O. W., Mar 1 2018, In: Journal of Clinical Oncology. 36, 7, p. 697-703 7 p.Research output: Contribution to journal › Article › peer-review
33 Scopus citations -
Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort
Rimsza, L. M., Li, H., Braziel, R. M., Spier, C. M., Persky, D. O., Dunlap, J., Leblanc, M., Bartlett, N., Leonard, J. P., Smith, S. M., Press, O. W. & Friedberg, J. W., Mar 23 2018, In: Haematologica. 103, 4, p. e151-e153Research output: Contribution to journal › Letter › peer-review
8 Scopus citations -
Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma
Kelly, K. R., Friedberg, J. W., Park, S. I., McDonagh, K., Hayslip, J., Persky, D., Ruan, J., Puvvada, S., Rosen, P., Iyer, S. P., Stefanovic, A., Bernstein, S. H., Weitman, S., Karnad, A., Monohan, G., VanderWalde, A., Mena, R., Schmelz, M., Spier, C., Groshen, S. & 5 others, , Dec 15 2018, In: Clinical Cancer Research. 24, 24, p. 6150-6159 10 p.Research output: Contribution to journal › Article › peer-review
13 Scopus citations -
Co-targeting aurora kinase with PD-L1 and PI3K abrogates immune checkpoint mediated proliferation in peripheral T-cell lymphoma: A novel therapeutic strategy
Islam, S., Vick, E., Huber, B., Morales, C., Spier, C., Cooke, L., Weterings, E. & Mahadevan, D., 2017, In: Oncotarget. 8, 59, p. 100326-100338 13 p.Research output: Contribution to journal › Article › peer-review
12 Scopus citations